The global market for Radioactive Iodine Ablation Therapy was valued at US$ 535 million in the year 2024 and is projected to reach a revised size of US$ 765 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Radioactive Iodine Ablation Therapy Market

Radioactive Iodine Ablation Therapy is a targeted internal radiotherapy that uses radioactive iodine-131 (I-131) to selectively destroy residual thyroid tissue or differentiated thyroid cancer cells. Leveraging the thyroid gland’s natural ability to concentrate iodine, the therapy delivers I-131 via oral or intravenous administration, enabling localized radiation deposition within the target tissue. It is widely applied in postoperative treatment of differentiated thyroid cancer, management of recurrent or metastatic lesions, and in selected cases of hyperthyroidism. Compared with surgery or external beam radiotherapy, radioactive iodine ablation offers high specificity, minimal invasiveness, and a standardized therapeutic workflow, making it a core modality in global nuclear medicine treatment pathways. With advances in nuclear medicine technologies, dosimetry, and isotope-supply systems, the therapy continues to serve as a crucial component in precision thyroid-disease management.The average gross profit margin of this product is 55%.

The demand for radioactive iodine ablation is rising as thyroid cancer screening improves and nuclear medicine infrastructure expands globally. Annual reports from pharmaceutical and nuclear-technology companies indicate sustained growth in differentiated thyroid cancer patients, along with increased clinical standardization of postoperative ablation therapy. Government investment in nuclear medicine departments, isotope-supply security, and radiopharmaceutical regulation provides strong industry support. Advances in radionuclide production, dosimetry, and formulation technologies continue to enhance precision and safety, strengthening clinical adoption.

Key challenges include the stability of isotope supply chains, stringent radiopharmaceutical regulations, and high compliance requirements for hospital nuclear facilities. Construction of nuclear medicine departments requires long cycles and significant investment, limiting adoption in some regions. Patient misconceptions regarding radiotherapy also necessitate continuous clinical education. Global supply-chain fluctuations may affect I-131 production and logistics, requiring robust inventory management. Emerging alternatives such as targeted therapies may introduce competitive pressure in select patient groups.

Demand is expanding across multiple medical tiers. Tertiary hospitals remain the primary users, prioritizing precision dosimetry and efficient treatment workflows. Regional medical centers are increasingly adopting nuclear-medicine capabilities, supported by government programs. Public information shows rising patient preference for personalized dosing, digital follow-up, and remote consultation, pushing institutions toward integrated treatment-management systems. The growth of multidisciplinary care pathways further strengthens collaborative diagnostic and therapeutic models.

Upstream components include I-131 isotope production, radiopharmaceutical formulation, lead-shielded transport devices, radiation measurement equipment, and nuclear-medicine consumables. National policies promoting nuclear-technology innovation and radiopharmaceutical localization enhance supply-chain security. Companies are improving formulation purity, protective packaging, and controlled-transport technology to ensure product quality. As regulatory systems mature, the upstream ecosystem is advancing toward higher standards, greater safety, and accelerated domestic substitution.

This report aims to provide a comprehensive presentation of the global market for Radioactive Iodine Ablation Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radioactive Iodine Ablation Therapy.

The Radioactive Iodine Ablation Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radioactive Iodine Ablation Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, by Care Setting and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Radioactive Iodine Ablation Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Radioactive Iodine Ablation Therapy Market Report

Report Metric	Details
Report Name	Radioactive Iodine Ablation Therapy Market
Accounted market size in year	US$ 535 million
Forecasted market size in 2031	US$ 765 million
CAGR	5.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Gamma Radiation Beta Radiation
Segment by Care Setting	Outpatient RAI Therapy Inpatient RAI Therapy
Segment by Administration	Capsule Form Liquid Form
Segment by Application	Papillary Thyroid Cancer Follicular Thyroid Cancer Hurthle Cell Carcinoma Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic, HealthTronics, Galil Medical, AngioDynamics, Misonix, SonaCare Medical, Boston Scientific Corporation, Neuwave Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Care Setting etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radioactive Iodine Ablation Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Radioactive Iodine Ablation Therapy Market growing?

Ans: The Radioactive Iodine Ablation Therapy Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Radioactive Iodine Ablation Therapy Market size in 2031?

Ans: The Radioactive Iodine Ablation Therapy Market size in 2031 will be US$ 765 million.

Who are the main players in the Radioactive Iodine Ablation Therapy Market report?

Ans: The main players in the Radioactive Iodine Ablation Therapy Market are Medtronic, HealthTronics, Galil Medical, AngioDynamics, Misonix, SonaCare Medical, Boston Scientific Corporation, Neuwave Medical

What are the Application segmentation covered in the Radioactive Iodine Ablation Therapy Market report?

Ans: The Applications covered in the Radioactive Iodine Ablation Therapy Market report are Papillary Thyroid Cancer, Follicular Thyroid Cancer, Hurthle Cell Carcinoma, Other

What are the Type segmentation covered in the Radioactive Iodine Ablation Therapy Market report?

Ans: The Types covered in the Radioactive Iodine Ablation Therapy Market report are Gamma Radiation, Beta Radiation

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Radioactive Iodine Ablation Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Gamma Radiation

1.2.3 Beta Radiation

1.3 Market by Care Setting

1.3.1 Global Radioactive Iodine Ablation Therapy Market Size Growth Rate by Care Setting: 2020 VS 2024 VS 2031

1.3.2 Outpatient RAI Therapy

1.3.3 Inpatient RAI Therapy

1.4 Market by Administration

1.4.1 Global Radioactive Iodine Ablation Therapy Market Size Growth Rate by Administration: 2020 VS 2024 VS 2031

1.4.2 Capsule Form

1.4.3 Liquid Form

1.5 Market by Application

1.5.1 Global Radioactive Iodine Ablation Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Papillary Thyroid Cancer

1.5.3 Follicular Thyroid Cancer

1.5.4 Hurthle Cell Carcinoma

1.5.5 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Radioactive Iodine Ablation Therapy Market Perspective (2020-2031)

2.2 Global Radioactive Iodine Ablation Therapy Growth Trends by Region

2.2.1 Global Radioactive Iodine Ablation Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Radioactive Iodine Ablation Therapy Historic Market Size by Region (2020-2025)

2.2.3 Radioactive Iodine Ablation Therapy Forecasted Market Size by Region (2026-2031)

2.3 Radioactive Iodine Ablation Therapy Market Dynamics

2.3.1 Radioactive Iodine Ablation Therapy Industry Trends

2.3.2 Radioactive Iodine Ablation Therapy Market Drivers

2.3.3 Radioactive Iodine Ablation Therapy Market Challenges

2.3.4 Radioactive Iodine Ablation Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Radioactive Iodine Ablation Therapy Players by Revenue

3.1.1 Global Top Radioactive Iodine Ablation Therapy Players by Revenue (2020-2025)

3.1.2 Global Radioactive Iodine Ablation Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Top Radioactive Iodine Ablation Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Radioactive Iodine Ablation Therapy Revenue

3.4 Global Radioactive Iodine Ablation Therapy Market Concentration Ratio

3.4.1 Global Radioactive Iodine Ablation Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Radioactive Iodine Ablation Therapy Revenue in 2024

3.5 Global Key Players of Radioactive Iodine Ablation Therapy Head office and Area Served

3.6 Global Key Players of Radioactive Iodine Ablation Therapy, Product and Application

3.7 Global Key Players of Radioactive Iodine Ablation Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Radioactive Iodine Ablation Therapy Breakdown Data by Type

4.1 Global Radioactive Iodine Ablation Therapy Historic Market Size by Type (2020-2025)

4.2 Global Radioactive Iodine Ablation Therapy Forecasted Market Size by Type (2026-2031)

5 Radioactive Iodine Ablation Therapy Breakdown Data by Application

5.1 Global Radioactive Iodine Ablation Therapy Historic Market Size by Application (2020-2025)

5.2 Global Radioactive Iodine Ablation Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Radioactive Iodine Ablation Therapy Market Size (2020-2031)

6.2 North America Radioactive Iodine Ablation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Radioactive Iodine Ablation Therapy Market Size by Country (2020-2025)

6.4 North America Radioactive Iodine Ablation Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Radioactive Iodine Ablation Therapy Market Size (2020-2031)

7.2 Europe Radioactive Iodine Ablation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Radioactive Iodine Ablation Therapy Market Size by Country (2020-2025)

7.4 Europe Radioactive Iodine Ablation Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Radioactive Iodine Ablation Therapy Market Size (2020-2031)

8.2 Asia-Pacific Radioactive Iodine Ablation Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Radioactive Iodine Ablation Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Radioactive Iodine Ablation Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Radioactive Iodine Ablation Therapy Market Size (2020-2031)

9.2 Latin America Radioactive Iodine Ablation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Radioactive Iodine Ablation Therapy Market Size by Country (2020-2025)

9.4 Latin America Radioactive Iodine Ablation Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Radioactive Iodine Ablation Therapy Market Size (2020-2031)

10.2 Middle East & Africa Radioactive Iodine Ablation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medtronic

11.1.1 Medtronic Company Details

11.1.2 Medtronic Business Overview

11.1.3 Medtronic Radioactive Iodine Ablation Therapy Introduction

11.1.4 Medtronic Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025)

11.1.5 Medtronic Recent Development

11.2 HealthTronics

11.2.1 HealthTronics Company Details

11.2.2 HealthTronics Business Overview

11.2.3 HealthTronics Radioactive Iodine Ablation Therapy Introduction

11.2.4 HealthTronics Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025)

11.2.5 HealthTronics Recent Development

11.3 Galil Medical

11.3.1 Galil Medical Company Details

11.3.2 Galil Medical Business Overview

11.3.3 Galil Medical Radioactive Iodine Ablation Therapy Introduction

11.3.4 Galil Medical Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025)

11.3.5 Galil Medical Recent Development

11.4 AngioDynamics

11.4.1 AngioDynamics Company Details

11.4.2 AngioDynamics Business Overview

11.4.3 AngioDynamics Radioactive Iodine Ablation Therapy Introduction

11.4.4 AngioDynamics Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025)

11.4.5 AngioDynamics Recent Development

11.5 Misonix

11.5.1 Misonix Company Details

11.5.2 Misonix Business Overview

11.5.3 Misonix Radioactive Iodine Ablation Therapy Introduction

11.5.4 Misonix Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025)

11.5.5 Misonix Recent Development

11.6 SonaCare Medical

11.6.1 SonaCare Medical Company Details

11.6.2 SonaCare Medical Business Overview

11.6.3 SonaCare Medical Radioactive Iodine Ablation Therapy Introduction

11.6.4 SonaCare Medical Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025)

11.6.5 SonaCare Medical Recent Development

11.7 Boston Scientific Corporation

11.7.1 Boston Scientific Corporation Company Details

11.7.2 Boston Scientific Corporation Business Overview

11.7.3 Boston Scientific Corporation Radioactive Iodine Ablation Therapy Introduction

11.7.4 Boston Scientific Corporation Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025)

11.7.5 Boston Scientific Corporation Recent Development

11.8 Neuwave Medical

11.8.1 Neuwave Medical Company Details

11.8.2 Neuwave Medical Business Overview

11.8.3 Neuwave Medical Radioactive Iodine Ablation Therapy Introduction

11.8.4 Neuwave Medical Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025)

11.8.5 Neuwave Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Boston Scientific Corporation

Neuwave Medical

List of Tables

Table 1. Global Radioactive Iodine Ablation Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Gamma Radiation

Table 3. Key Players of Beta Radiation

Table 4. Global Radioactive Iodine Ablation Therapy Market Size Growth Rate by Care Setting (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of Outpatient RAI Therapy

Table 6. Key Players of Inpatient RAI Therapy

Table 7. Global Radioactive Iodine Ablation Therapy Market Size Growth Rate by Administration (US$ Million): 2020 VS 2024 VS 2031

Table 8. Key Players of Capsule Form

Table 9. Key Players of Liquid Form

Table 10. Global Radioactive Iodine Ablation Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Radioactive Iodine Ablation Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 12. Global Radioactive Iodine Ablation Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 13. Global Radioactive Iodine Ablation Therapy Market Share by Region (2020-2025)

Table 14. Global Radioactive Iodine Ablation Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 15. Global Radioactive Iodine Ablation Therapy Market Share by Region (2026-2031)

Table 16. Radioactive Iodine Ablation Therapy Market Trends

Table 17. Radioactive Iodine Ablation Therapy Market Drivers

Table 18. Radioactive Iodine Ablation Therapy Market Challenges

Table 19. Radioactive Iodine Ablation Therapy Market Restraints

Table 20. Global Radioactive Iodine Ablation Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 21. Global Radioactive Iodine Ablation Therapy Market Share by Players (2020-2025)

Table 22. Global Top Radioactive Iodine Ablation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioactive Iodine Ablation Therapy as of 2024)

Table 23. Ranking of Global Top Radioactive Iodine Ablation Therapy Companies by Revenue (US$ Million) in 2024

Table 24. Global 5 Largest Players Market Share by Radioactive Iodine Ablation Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 25. Global Key Players of Radioactive Iodine Ablation Therapy, Headquarters and Area Served

Table 26. Global Key Players of Radioactive Iodine Ablation Therapy, Product and Application

Table 27. Global Key Players of Radioactive Iodine Ablation Therapy, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Radioactive Iodine Ablation Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 30. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Type (2020-2025)

Table 31. Global Radioactive Iodine Ablation Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 32. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Type (2026-2031)

Table 33. Global Radioactive Iodine Ablation Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 34. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Application (2020-2025)

Table 35. Global Radioactive Iodine Ablation Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 36. Global Radioactive Iodine Ablation Therapy Revenue Market Share by Application (2026-2031)

Table 37. North America Radioactive Iodine Ablation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. North America Radioactive Iodine Ablation Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 39. North America Radioactive Iodine Ablation Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 40. Europe Radioactive Iodine Ablation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Europe Radioactive Iodine Ablation Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Europe Radioactive Iodine Ablation Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Asia-Pacific Radioactive Iodine Ablation Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 44. Asia-Pacific Radioactive Iodine Ablation Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 45. Asia-Pacific Radioactive Iodine Ablation Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 46. Latin America Radioactive Iodine Ablation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Latin America Radioactive Iodine Ablation Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 48. Latin America Radioactive Iodine Ablation Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 49. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 50. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 51. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 52. Medtronic Company Details

Table 53. Medtronic Business Overview

Table 54. Medtronic Radioactive Iodine Ablation Therapy Product

Table 55. Medtronic Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025) & (US$ Million)

Table 56. Medtronic Recent Development

Table 57. HealthTronics Company Details

Table 58. HealthTronics Business Overview

Table 59. HealthTronics Radioactive Iodine Ablation Therapy Product

Table 60. HealthTronics Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025) & (US$ Million)

Table 61. HealthTronics Recent Development

Table 62. Galil Medical Company Details

Table 63. Galil Medical Business Overview

Table 64. Galil Medical Radioactive Iodine Ablation Therapy Product

Table 65. Galil Medical Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025) & (US$ Million)

Table 66. Galil Medical Recent Development

Table 67. AngioDynamics Company Details

Table 68. AngioDynamics Business Overview

Table 69. AngioDynamics Radioactive Iodine Ablation Therapy Product

Table 70. AngioDynamics Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025) & (US$ Million)

Table 71. AngioDynamics Recent Development

Table 72. Misonix Company Details

Table 73. Misonix Business Overview

Table 74. Misonix Radioactive Iodine Ablation Therapy Product

Table 75. Misonix Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025) & (US$ Million)

Table 76. Misonix Recent Development

Table 77. SonaCare Medical Company Details

Table 78. SonaCare Medical Business Overview

Table 79. SonaCare Medical Radioactive Iodine Ablation Therapy Product

Table 80. SonaCare Medical Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025) & (US$ Million)

Table 81. SonaCare Medical Recent Development

Table 82. Boston Scientific Corporation Company Details

Table 83. Boston Scientific Corporation Business Overview

Table 84. Boston Scientific Corporation Radioactive Iodine Ablation Therapy Product

Table 85. Boston Scientific Corporation Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025) & (US$ Million)

Table 86. Boston Scientific Corporation Recent Development

Table 87. Neuwave Medical Company Details

Table 88. Neuwave Medical Business Overview

Table 89. Neuwave Medical Radioactive Iodine Ablation Therapy Product

Table 90. Neuwave Medical Revenue in Radioactive Iodine Ablation Therapy Business (2020-2025) & (US$ Million)

Table 91. Neuwave Medical Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Radioactive Iodine Ablation Therapy Picture

Figure 2. Global Radioactive Iodine Ablation Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Radioactive Iodine Ablation Therapy Market Share by Type: 2024 VS 2031

Figure 4. Gamma Radiation Features

Figure 5. Beta Radiation Features

Figure 6. Global Radioactive Iodine Ablation Therapy Market Size Comparison by Care Setting (2020-2031) & (US$ Million)

Figure 7. Outpatient RAI Therapy Features

Figure 8. Inpatient RAI Therapy Features

Figure 9. Global Radioactive Iodine Ablation Therapy Market Size Comparison by Administration (2020-2031) & (US$ Million)

Figure 10. Capsule Form Features

Figure 11. Liquid Form Features

Figure 12. Global Radioactive Iodine Ablation Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Radioactive Iodine Ablation Therapy Market Share by Application: 2024 VS 2031

Figure 14. Papillary Thyroid Cancer Case Studies

Figure 15. Follicular Thyroid Cancer Case Studies

Figure 16. Hurthle Cell Carcinoma Case Studies

Figure 17. Other Case Studies

Figure 18. Radioactive Iodine Ablation Therapy Report Years Considered

Figure 19. Global Radioactive Iodine Ablation Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 20. Global Radioactive Iodine Ablation Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 21. Global Radioactive Iodine Ablation Therapy Market Share by Region: 2024 VS 2031

Figure 22. Global Radioactive Iodine Ablation Therapy Market Share by Players in 2024

Figure 23. Global Radioactive Iodine Ablation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 24. The Top 10 and 5 Players Market Share by Radioactive Iodine Ablation Therapy Revenue in 2024

Figure 25. North America Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. North America Radioactive Iodine Ablation Therapy Market Share by Country (2020-2031)

Figure 27. United States Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Canada Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Radioactive Iodine Ablation Therapy Market Share by Country (2020-2031)

Figure 31. Germany Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. France Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. U.K. Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Italy Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Russia Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Ireland Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Radioactive Iodine Ablation Therapy Market Share by Region (2020-2031)

Figure 39. China Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Japan Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. South Korea Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. India Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Australia & New Zealand Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Radioactive Iodine Ablation Therapy Market Share by Country (2020-2031)

Figure 47. Mexico Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Brazil Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Radioactive Iodine Ablation Therapy Market Share by Country (2020-2031)

Figure 51. Israel Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. UAE Radioactive Iodine Ablation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Medtronic Revenue Growth Rate in Radioactive Iodine Ablation Therapy Business (2020-2025)

Figure 55. HealthTronics Revenue Growth Rate in Radioactive Iodine Ablation Therapy Business (2020-2025)

Figure 56. Galil Medical Revenue Growth Rate in Radioactive Iodine Ablation Therapy Business (2020-2025)

Figure 57. AngioDynamics Revenue Growth Rate in Radioactive Iodine Ablation Therapy Business (2020-2025)

Figure 58. Misonix Revenue Growth Rate in Radioactive Iodine Ablation Therapy Business (2020-2025)

Figure 59. SonaCare Medical Revenue Growth Rate in Radioactive Iodine Ablation Therapy Business (2020-2025)

Figure 60. Boston Scientific Corporation Revenue Growth Rate in Radioactive Iodine Ablation Therapy Business (2020-2025)

Figure 61. Neuwave Medical Revenue Growth Rate in Radioactive Iodine Ablation Therapy Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32T20006

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0Q20500

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-18V16958

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

Published Date: December 2025

Report Code: QYRE-Auto-9U20281

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

FEATURED COMPANIES

Radioactive Iodine Ablation Therapy Market Size

Radioactive Iodine Ablation Therapy Market

Scope of Radioactive Iodine Ablation Therapy Market Report

Chapter Outline

FAQ for this report

How fast is Radioactive Iodine Ablation Therapy Market growing?

What is the Radioactive Iodine Ablation Therapy Market size in 2031?

Who are the main players in the Radioactive Iodine Ablation Therapy Market report?

What are the Application segmentation covered in the Radioactive Iodine Ablation Therapy Market report?

What are the Type segmentation covered in the Radioactive Iodine Ablation Therapy Market report?

FEATURED COMPANIES

RELATED REPORTS